ThursdayJul 06, 2023 9:00 am

Genprex, Inc. (NASDAQ: GNPX) Receives Third Fast Track Designation for REQORSA(R), Setting Stage for Commencement of Acclaim-3 Clinical Trial in Q3

Genprex recently received a Fast Track Designation (“FTD”) from the FDA for its REQORSA(R) Immunogene Therapy in combination with Genentech, Inc.’s Tecentriq(R) in patients with extensive-stage small cell lung cancer This is Genprex’s third FTD and sets the stage for the initiation of its third lung cancer clinical trial, Acclaim-3 Acclaim-3 clinical trial is a Phase 1/2 dose escalation and clinical response study of maintenance therapy evaluating REQORSA in combination with Tecentriq The company expects to enroll the first patient in its Acclaim-3 clinical trial in the third quarter of 2023 Genprex is combining its lead product candidate, REQORSA, with…

Continue Reading

WednesdayJul 05, 2023 12:19 pm

How eCommerce Could Help Rebuild Consumer Trust in Healthcare Sector

Surveys have shown that a majority of Americans do not trust the healthcare sector, with only 23% of customers reporting that they fully trust the industry. Given the critical role played by the healthcare industry, it is essential that healthcare providers find better and more efficient ways of rebuilding customer trust. Turning to e-commerce may allow healthcare companies to bridge this gap and provide higher-quality services to patients. The internet and digitization were game changers for commerce in general, and they have completely changed how businesses operate. These days, any entrepreneur worth their salt has an online presence and leverages…

Continue Reading

MondayJul 03, 2023 10:15 am

Research Maps Neighborhoods of Psoriasis Cells in Attempt to Understand Condition

Researchers are leveraging new mapping techniques to study psoriasis cells to understand the condition better. Psoriasis occurs when the immune system becomes overactive and causes inflammation in the skin, resulting in the formation of raised patches of red, itchy, flaky skin. While psoriasis symptoms can range from mild to severe, the condition also increases the risk of developing health conditions such as diabetes, mental health issues, psoriatic arthritis and heart problems. Scientists have been unable to determine why psoriasis makes it easier to develop other conditions for decades. With this new mapping technique, however, researchers could generate accurate maps of…

Continue Reading

MondayJul 03, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMO Services

BiondVax’s CDMO services allow the company to partner with pharmaceutical companies to provide contract-based drug development and manufacturing services BiondVax showcased its boutique end-to-end CDMO offering at the annual Biomed Conference in Tel Aviv in May BiondVax’s cGMP biologics manufacturing facility in Jerusalem is fully equipped with state-of-the-art CDMO capabilities The expansion of CDMO services will augment revenue and expand pharma contacts while still maintaining BiondVax’s core focus of NanoAb therapies for significant indications like COVID-19, psoriasis, asthma, and more BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment…

Continue Reading

FridayJun 30, 2023 10:49 am

Immunotherapy Implants Could Turn Tumor Cells on Each Other

Immunotherapy is a relatively recent type of cancer treatment that involves boosting the immune system to make it more effective at finding and killing cancer cells. It is often deployed together with other treatments such as chemotherapy to kill off as many cancer cells as possible and prevent them from growing. However, treating solid tumors using immunotherapy can be extremely difficult as tumors are heterogeneous, meaning each person’s tumor is different. This makes it harder to create general “one size fits all” treatments for cancer patients, even when they are suffering from the same type of cancer. A research team…

Continue Reading

ThursdayJun 29, 2023 10:44 am

Exploring the Link Between Hypertension, Asthma

On average, asthma affects close to 26 million people, or 1 in every 13 people in the United States with nearly 21 million adults aged 18 years and older suffering from the respiratory condition. Doctors advise most asthma patients to follow steps such as religiously taking medication, implementing healthy lifestyle habits, and avoiding triggers to keep the condition under control and prevent asthma attacks. Asthma patients are also advised to keep an eye on their blood pressure numbers as hypertension is closely tied to the presence of asthma. Hypertension, or high blood pressure, is characterized by chest pain, severe headaches,…

Continue Reading

WednesdayJun 28, 2023 1:08 pm

How to Make the Most of Your Health Savings Account

As the cost of healthcare continues to rise and inflation continues to increase, finding ways to save money will benefit many. Given that those with health savings accounts, commonly referred to as HSAs, can contribute more following recent increases to the limits to people’s contributions to HSAs, Health-E Commerce has shared some tips to maximize value from these limit increases. Health-E Commerce is the parent company of HSA Store, WellDeservedHealth and FSA Store, a collection of digital marketplaces that serve millions of consumers registered in pretax medical as well as wellness accounts. These tips include: Using online tools to project…

Continue Reading

TuesdayJun 27, 2023 12:10 pm

Study Concludes Early Eczema Points to Future Allergy Development

German researchers recently published a study indicating that the presence of eczema in early childhood can lead to the development of allergies in the future. Also known as atopic dermatitis or atopic eczema, the skin condition affects up to 20% of children, or roughly 9.6 million children under 18 in the United States. Children are more likely to develop eczema than adults, and around one-third of them will experience moderate to severe symptoms of eczema once the condition manifests. Research findings published in the “Nutrients” journal examined the potential long-term effects of developing eczema in the first three years of…

Continue Reading

MondayJun 26, 2023 11:56 am

Virus Therapy Plus Radiation Could Improve Brain Tumor Treatment, Study Finds

University of Alberta researchers may have devised an extra-effective brain tumor treatment by combining radiation therapy with a cancer-targeting virus. The researchers found that the combination of both treatments was more effective at treating brain cancer in mice than taking the treatments separately, indicating that scientists could develop effective cancer treatments by combining existing therapies. Brain cancer is a deadly disease that is characterized by the development and spread of tumors in the brain and has exceedingly poor health outcomes.  Like most cancers, brain tumors have no cure. Most treatment efforts involve killing off as many cancer cells as possible…

Continue Reading

FridayJun 23, 2023 10:02 am

Why Women with MS See Decreased Symptoms When Pregnant

Most people with multiple sclerosis (MS) are women (74%), while men comprise only 24% of MS patients. Women are three times more likely to develop multiple sclerosis, and the National Multiple Sclerosis Society states that more women are developing the condition as time passes.  Although we still haven’t figured out what exactly causes MS, researchers posit that factors such as stress, smoking, hormones such as estrogen, and inflammation may increase the risk of developing multiple sclerosis. Many women with the condition have noticed that their symptoms decrease when they are pregnant, with some reporting a significant reduction in symptoms during…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000